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Abstract
TdIF1 was originally identified as a protein that directly binds to DNA polymerase TdT. TdIF1 is also thought to function in
transcription regulation, because it binds directly to the transcriptional factor TReP-132, and to histone deacetylases HDAC1
and HDAC2. Here we show that TdIF1 recognizes a specific DNA sequence and regulates gene transcription. By constructing
TdIF1 mutants, we identify amino acid residues essential for its interaction with DNA. An in vitro DNA selection assay, SELEX,
reveals that TdIF1 preferentially binds to the sequence 59-GNTGCATG-39 following an AT-tract, through its Helix-Turn-Helix
and AT-hook motifs. We show that four repeats of this recognition sequence allow TdIF1 to regulate gene transcription in a
plasmid-based luciferase reporter assay. We demonstrate that TdIF1 associates with the RAB20 promoter, and RAB20 gene
transcription is reduced in TdIF1-knocked-down cells, suggesting that TdIF1 stimulates RAB20 gene transcription.
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Introduction
TdT interacting factor 1 (TdIF1), encoded by DNTTIP1, was
first identified as a protein that directly binds to terminal
deoxynucleotidyltransferase (TdT) [1]. TdT contributes to the
diversity of immunoglobulins and T-cell receptors in lymphocytes
[2,3]. TdIF1 negatively regulates TdT activity [1,4,5] and controls
TdT degradation through the Bood POZ-containing gene type-2
(BPOZ-2)-mediated ubiquitin proteasome system [6,7]. These
previous studies showed that TdIF1 controls TdT in lymphocytes
at the post-translational level.
TdT is expressed specifically in lymphocytes, but TdIF1 is
expressed ubiquitously suggesting it has additional biological
functions. TdIF1 orthologues are even found in invertebrates, such
as Caenorhabditis elegans (C. elegans), which do not possess a TdT gene
[5,8], strongly suggesting that TdIF1 functions in non-lymphoid as
well as lymphoid cells. Several lines of evidence implicate TdIF1 in
controlling transcription. Human TdIF1 is reported to bind to
TReP-132 (also known as TRERF1), a transcriptional co-activator
of steroidogenic factor 1, which induces p450scc gene expression
in steroid-hormone-producing cells [4,9]. In addition, in M-phase
cells human TdIF1 associates with histone deacetylases HDAC1
and HDAC2 in a multisubunit complex [10], that may act in
transcriptional regulation. In C. elegans, the TdIF1 orthologue also
associates with the TReP-132 orthologue and with histone
deacetylase HDA-2, and is suggested to act downstream of
cGMP-dependent protein kinase to regulate gene expression [8].
TdIF1 is a 37-kDa DNA-binding protein that contains three
DNA-binding regions: within residues 1–75, an AT-hook domain
between residues 159–173, and a predicted helix-turn-helix (HTH)
region between residues 184–243 [5]. The AT-hook, which was
first described in the high-mobility-group non-histone chromo-
somal protein HMGA, binds to AT-tracts in the minor groove of
DNA [11,12]. The HTH is a short structural motif consisting of a
first a-helix, a connecting turn, and a second helix, which
generally recognizes a specific DNA sequence [13]. While TdIF1
binds to AT-tracts through the AT-hook [5], no evidence has been
reported for recognition of a specific DNA sequence by the
predicted HTH of TdIF1.
Here we show that basic amino acids present in the three DNA-
binding regions of TdIF1 (residues 1–75, AT-hook, and HTH) are
required for its DNA binding. Using an in vitro binding sequence
selection assay (SELEX), and competitive electrophoretic mobility
shift assay (EMSA), we find that TdIF1 preferentially binds to the
specific DNA sequence 59-GNTGCATG-39 where it follows AT-
tracts, through its AT-hook and HTH domains. Furthermore, we
showed that these recognition sequences allow TdIF1 to up-
regulate gene transcription in a luciferase reporter system. Finally,
we show that TdIF1 associates with the promoter region of the
RAB20 gene to regulate its transcription.
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Results
Basic amino acid residues in three DNA-binding regions
of TdIF1 important for its DNA binding
We previously showed that TdIF1 binds to dsDNA through
three regions: residues 1–75, an AT-hook spanning residues 159–
173, and residues 184–243 containing a predicted HTH [5]. To
identify the amino acid residues that bind to DNA, we constructed
a series of TdIF1 mutants (Figure 1A). Residues 48–54 are
predicted by DISOPRED to produce a disordered, structurally
flexible region that could potentially bind DNA or proteins [14], so
in a C-terminally truncated TdIF1 protein we replaced R50 and
R52 with alanines (1–183mtN). We also introduced two missense
mutations in the AT hook region (1–183mtAT), similar to
mutations made in AT-hook protein HMGA [15]. To determine
whether the predicted HTH binds to DNA, in an N-terminally
truncated TdIF1 we replaced K235 with alanine (184–
329mtHTH1). K235 lies in the second helix of the HTH motif
and is conserved from C. elegans to humans. We also replaced other
two basic amino acid residues in the second helix with alanines
(184–329mtHTH2), because the second helix in an HTH is
generally considered to recognize a specific DNA sequence [13]
and positively charged amino acids may contact DNA phosphates
[16]. Finally, we constructed a mutant mtNAH, with all these
point mutations in the full-length TdIF1.
To examine the DNA-binding activity of these mutants, we
performed GST pull-out assays (Figure 1B) [5]. DNA fragments
produced by digesting the pcDNA3.1 plasmid with Hae III were
incubated with GST-fused TdIF1 immobilized on glutathione
Sepharose beads. The DNA fragments that bound to TdIF1 were
sequentially eluted with buffer containing 150–300 mM NaCl and
analysed by PAGE. This assay allows us to test DNA-binding
activity and affinity of TdIF1 and TdIF1 mutants. As shown in
Figure 1C, the DNA-binding activity of 1–183mtN was slightly
decreased (lanes 7–10) compared to that of wild-type 1–183 (lanes
3–6). While 1–183mtAT weakly bound to DNA (lanes 11–14), 1–
183mtNA did not detectably bind to DNA at all (lanes 15–18).
These results indicate that both the 1–75 region and the AT-hook
are required for the full DNA-binding activity of residues 1–183,
and that R50 and R52 are crucial for the DNA binding of residues
1–75. In a similar assay 184–329mtHTH2 lost most of its DNA-
binding ability (lanes 29–32), indicating that the predicted HTH in
TdIF1 functions as a DNA-binding domain. As shown in
Figure 1D, mtNAH showed little capacity to bind DNA in this
assay. Taken together, our results indicate that basic amino acids
in residues 48–54, the AT-hook, and the HTH all contribute to
TdIF1’s DNA-binding activity.
Identification of the TdIF1-binding DNA sequences by
SELEX
The AT-hook in TdIF1 preferentially binds to AT-rich
sequences [5]. HTHs generally recognize specific DNA sequences;
for example, the HTHs in Prrx2, Nkx3.2, and PBX1 recognize 59-
AATTA-39, 59-HRAGTG-39, and 59-ATCAATCA-39, respec-
tively [13,17–19]. Although DNA binding of TdIF1 appears fairly
promiscuous under the conditions in Figure 1, we wished to test
the possibility that TdIF1 preferentially binds to a specific DNA
sequence through its AT-hook and HTH. We used the random
oligonucleotide binding selection strategy (SELEX) to investigate
TdIF1-binding DNA sequences (Figure 2A). Purified TdIF1 was
incubated with a pool of random 36-bp DNAs flanked by linker
sequences (so each fragment has total length 76 bp). DNA that
bound to TdIF1 was isolated by EMSA (Figure 2B) and recovered
from the shifted band, then amplified by PCR and used for a
second cycle of SELEX. After 10 rounds of selection, the pool of
DNA fragments was sub-cloned into the pBS vector, and the DNA
sequences of 17 independent clones determined.
Eleven of the 17 clones contained a continuous run of at least six
As or Ts (Figure 2C, red letters), which were probably recognized
by the AT-hook. Interestingly, 13 of the 17 clones contained the
sequence 59-GNTGCATG-39 and the remaining four contained a
similar sequence (Figure 2C, underlined). We aligned these
sequences to produce a LOGO (Figure 2D) [20]. This analysis
reveals that the HTH or residues 1–75 of TdIF1 recognize 59-
GNTGCATG-39. Our finding of an AT-tract generally present
upstream of the 59-GNTGCATG-39 motif suggests that TdIF1
preferentially binds to the sequence 59-GNTGCATG-39 following
an AT-tract.
TdIF1 preferentially binds to 59-GNTGCATG-39, and the
binding is enhanced by consecutive AT nucleotides
To confirm that TdIF1 preferentially binds to 59-
GNTGCATG-39 following an AT-tract, we performed compet-
itive EMSA. We used biotin-labelled AT-rich dsDNA (biotin-
dsAT) as a probe (Figure 3A), since it has been previously shown
that TdIF1 can bind to the AT-rich probe in EMSA [5]. The
probe contains two long AT-tracts (12 bp each) (Figure 3A), which
can be recognized by AT-hook in TdIF1. To confirm that TdIF1
preferentially recognizes TdIF1 binding sequence (i.e., 59-
GNTGCATG-39 following an AT-tract) rather than an AT-tract,
we tested whether binding of the AT-rich probe to TdIF1 could be
competed by unlabelled ds-oligo DNAs containing the TdIF1-
binding DNA sequences (Competitor I in Figure 3A, correspond-
ing to clone 10 in Figure 2C) or by mutated TdIF1-binding
sequences (Competitors II-IV in Figure 3A). As shown in
Figure 3B, the TdIF1/biotin-dsAT complex decreased with
increasing amounts of ds-oligo competitor I, containing both the
AT-tract and 59-GNTGCATG-39 (lanes 3–5), whereas the
TdIF1/biotin-dsAT complex did not decrease markedly with the
ds-oligo competitor II containing only the AT-tract (lanes 6-8),
indicating that TdIF1 preferentially recognizes 59-GNTGCATG-
39. The competitor II contains an AT-tract, but the competitor II
did not inhibit the formation of TdIF1/biotin-dsAT efficiently
(lanes 6–8). This is probably because AT-hook in TdIF1 prefers
two long AT-tracts in the probe to an AT-tract in the competitor.
The addition of a ds-oligo competitor III containing only 59-
GNTGCATG-39 to the reaction mixture reduced the amount of
TdIF1/biotin-dsAT complex (lanes 9–11), but its effect was
slightly weaker than that of the ds-oligo containing both 59-
GNTGCATG-39 and the AT-tract (compare lane 11 with lane 5).
These results showed that TdIF1 mainly recognizes 59-
GNTGCATG-39, and its DNA binding is moderately enhanced
by a flanking AT-rich sequence.
The HTH in TdIF1 recognizes 59-GNTGCATG-39
To examinewhether theHTH inTdIF1 preferentially recognizes
59-GNTGCATG-39, we performed EMSA using purified full-
length TdIF1mtHTH2, which contains intact AT-hook and the
mutated HTH. TdIF1mtHTH2 bound to the AT-rich dsDNA
probe, probably through AT-hook (Figure 3C, lane 2). The addition
of a competitor I containing 59-GNTGCATG-39 reduced the
amount of the wild-type TdIF1/biotin-dsAT complex (lanes 8 and
9), but did not reduce the TdIF1mtHTH2/biotin-dsAT complex
significantly (lanes 3 and 4), indicating that TdIF1mtHTH2 did not
recognize 59-GNTGCATG-39. These results collectively indicate
that HTH recognizes 59-GNTGCATG-39, but the region contain-
ing residues 1–75 does not.
TdIF1, A Novel Transcriptional Factor
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TdIF1 up-regulates gene transcription in a luciferase
reporter assay
Since TdIF1 interacts with the transcriptional co-activator
TReP-132 [4] and recognizes an AT-tract followed by 59-
GNTGCATG-39 in vitro, we tested if TdIF1 is involved in gene
transcription by binding to a promoter region. To examine this
possibility, we performed a reporter assay in 293T cells using a
plasmid harbouring four repeats of the TdIF1 DNA-binding site
59-AAATTTGTTGCATG-39 in the upstream-promoter region of
a luciferase gene. As shown in Figure 4A (columns 1 and 3), the
reporter gene transcription was increased 1.4-fold by the presence
of the TdIF1-binding DNA sequence, suggesting that endogenous
TdIF1 bound to the TdIF1-binding motif and promoted the
reporter gene transcription. We then assayed the transcriptional
activity in 293T cells transiently over-expressing EGFP-TdIF1. As
shown in Figure 4A (columns 3 and 4), over-expression of EGFP-
TdIF1 up-regulated the transcription 5-fold, strongly suggesting
that TdIF1 functions as a transcriptional factor. Like over-
expression of EGFP-fused TdIF1, over-expression of non-tagged
TdIF1 up-regulated the transcription (data not shown), indicating
that EGFP-tag does not affect the function of TdIF1 in
transcription. Based on our analysis of its sequence preference,
Figure 1. Basic amino acids in residues 1–75, an AT-hook, and an HTH of TdIF1 are required for its DNA-binding activity. (A)
Schematic representation of TdIF1 mutants and summary of their DNA binding activity. DNA binding regions which are previously determined [5] are
shown below the schematic representation of TdIF1. ‘‘DNA-binding’’ shows summary of GST pull-out assay shown in panels C and D: DNA fragments
were held by TdIF1 or TdIF1 mutants until elution in buffer containing 300 mM NaCl (++++), 250 mM (+++), 200 mM (++) or 150 mM (+), or DNA
fragments were not held (2). NLS, nuclear localization signal. (B) Schematic flowchart of GST pull-out assay. (C) DNA-binding activities of TdIF1
mutants. Hae III-digested pcDNA3.1 plasmid was incubated with TdIF1 mutants, and then DNA fragments bound to TdIF1 mutants were sequentially
eluted with buffer A containing 150, 200, 250, or 300 mM NaCl, separated by PAGE, and detected by silver staining. Lanes 1 and 19 contained a 200-
bp DNA ladder marker. Lanes 2 and 20 contained 1/5 of the amount of pcDNA3.1/Hae III used in the reaction. Asterisk indicates higher molecular
weight bands, which are probably a complex of DNA and protein eluted. (D) DNA-binding activity of full-length TdIF1 containing point mutations.
DNA fragments bound to TdIF1 mutants were sequentially eluted with buffer containing 200, 250, 300, or 350 mM NaCl, and analysed as in (C).
doi:10.1371/journal.pone.0066710.g001
TdIF1, A Novel Transcriptional Factor
PLOS ONE | www.plosone.org 3 July 2013 | Volume 8 | Issue 7 | e66710
TdIF1, A Novel Transcriptional Factor
PLOS ONE | www.plosone.org 4 July 2013 | Volume 8 | Issue 7 | e66710
we propose that TdIF1 binds the 59-AAATTTGTTGCATG-39
sequence to up-regulate reporter gene transcription.
We next determined the regions in TdIF1 required for the up-
regulation of transcription. For this analysis, we performed the
luciferase assay using truncated mutants of TdIF1 (EGFP-TdIF1
wild-type, EGFP-TdIF1 1–183, and EGFP-TdIF1 184–329). As
shown in Figure 4B, both the N-terminal and C-terminal regions
of TdIF1 up-regulated the reporter gene transcription, suggesting
that each region alone could promote gene transcription, although
neither individual region up-regulated the transcription as
Figure 2. Identification of the DNA sequences recognized by TdIF1 by SELEX. (A) Flow chart of the SELEX experiment. (B) EMSA results in
the 7th cycle. DNA was detected by EtBr staining. The arrow indicates the TdIF1/oligoDNA complex. (C) Oligonucleotides selected by SELEX aligned
around the identified consensus 59-GNTGCATG-39, underlined in each case. Sequences of six or more continuous As or Ts are in red. Flanking linker
sequence shown in italics. (D) Conserved nucleotides drawn as a sequence logo [20].
doi:10.1371/journal.pone.0066710.g002
Figure 3. TdIF1 preferentially recognizes 59-GNTGCATG-39 following an AT-tract. (A) Sequences of the biotin-labelled AT-rich probe and
the competitors used. Asterisks indicate replaced residues in the AT-tract or 59-GNTGCATG-39 motifs. (B) Competitive EMSA. All reaction mixtures
contained 5 pmol of biotin-labelled AT-rich probe. Purified His-TdIF1 (100 ng) was incubated in the reaction mixture alone or with competitors (5, 15,
or 45 pmol) as indicated (lanes 2–14). (C) Competitive EMSA using TdIF1mtHTH2, which has mutations in the HTH. TdIF1mtHTH2 (200 ng) or wild-
type TdIF1 (100 ng) was incubated with biotin-labelled AT-rich probe alone or with competitors (15 or 45 pmol), as indicated.
doi:10.1371/journal.pone.0066710.g003
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efficiently as the full-length TdIF1. We also performed the
luciferase assay using the TdIF1 point mutant mtNAH
(Figure 4B), which hardly binds to DNA in vitro (Figure 1D).
mtNAH was less able to induce luciferase activity, suggesting that
TdIF1 promotes gene transcription by binding to the TdIF1-
binding DNA sequence. The remaining increase in luciferase
activity caused by mtNAH may imply that the mutant protein
retains some ability to induce transcription, or alternatively that
TdIF1 also affects luciferase activity indirectly, possibly through
regulation of mRNA or protein level. The latter idea is consistent
with the observation that over-expression of TdIF1 caused some
increase of luciferase activity even in the absence of TdIF1-binding
sequence (Figure 4A, column 2).
TdIF1 regulates transcription of the RAB20 gene
We next searched for genes with the TdIF1-binding DNA
sequence in their promoter region, using the cis-regulatory
element database (cisRED) program [21,22]. We searched for
59-GTTGCATG-39 alone, because this sequence was most
frequently detected one in our SELEX experiment (Figure 2);
the AT-tract did not appear to be essential for the DNA binding of
TdIF1 (Figures 2 and 3). We identified 22 genes with 59-
GTTGCATG-39 in their promoter region (Table S2).
We next examined whether TdIF1 actually associated with the
promoter region of the candidate genes. To test this, we performed
ChIP-qPCR assays using an anti-Flag antibody and 293T cells
expressing Flag-TdIF1. As shown in Figure 5A, the promoter
region of RAB20 was significantly amplified, with a ChIP
efficiency of 0.45%. No association of TdIF1 with the ADSS or
Znf331 promoter was detected (Figure 5A). While the ADSS and
Znf331 promoters contain 59-GTTGCATG-39 only, the RAB20
promoter contains both 59-GTTGCATG-39 and an AT-tract
(Figure 5B), indicating that the AT-tract may be essential for
TdIF1’s binding in vivo.
We then determined whether TdIF1 actually regulates RAB20
gene transcription in cells. The RAB20 mRNA in TdIF1 knocked-
down cells was compared with that in control cells by quantitative
RT-PCR. As shown in Figure 5C, the RAB20 mRNA decreased
in the TdIF1 knocked-down cells (siTdIF1) to 37% of the level in
control cells (siNega), suggesting that TdIF1 up-regulates the
RAB20 gene transcription. TdIF1 knock-down was confirmed, as
demonstrated by decrease in mRNA level of DNTTIP1, which
encodes TdIF1 (Figure 5C). The mRNA level of ADSS also
decreased in TdIF1 knocked-down cells (Figure 5C), suggesting
that TdIF1 may also regulate ADSS gene expression. We did not
detect any association of TdIF1 with the ADSS promoter
(Figure 5A), but it may bind at a level below our detection
threshold. Alternatively, TdIF1 might regulate ADSS gene
transcription indirectly.
Discussion
We have shown that basic amino acids in residues 48–54, the
AT-hook, and the HTH are required for TdIF1 DNA-binding
activity. We find moreover that TdIF1 preferentially binds to a
specific DNA sequence, 59-GNTGCATG-39 following an AT-
tract, through its AT-hook and HTH. This TdIF1-binding DNA
sequence is present in the promoter of the RAB20 gene, shown
here to be up-regulated by TdIF1.
The length of TdIF1’s DNA-binding sequence, 59-
GNTGCATG-39, is consistent with previous findings that HTH
transcriptional factors recognize specific DNA sequences of 5-8
bps. For example Prrx2, Nkx3.2, and PBX1 recognize 59-
AATTA-39, 59-HRAGTG-39, and 59-ATCAATCA-39, respec-
tively [13,17–19]. It is presently unclear whether the third DNA-
binding region (1–75 aa) contributes to specific DNA sequence
recognition. Certain arginine-rich motifs do contribute to the
specific- and non-specific RNA/DNA sequence recognition, for
Figure 4. TdIF1 promotes transcription in a luciferase reporter
assay. (A) TdIF1 promotes transcription. The pGL3-promoter-TdIF1-
binding sequence and pRL-TK were co-transfected with pEGFP or
pEGFP-TdIF1 into 293T cells, and the luciferase activity was assayed. The
relative luciferase activity was normalized to the value obtained with
the pGL3-promoter and pEGFP. Error bars represent S.E.M. Samples
significantly different from the control are indicated by asterisks
(p,0.01). (B) TdIF1 promotes transcription by directly binding to
DNA. The pGL3-promoter-TdIF1-binding sequence and pRL-TK were co-
transfected with pEGFP-TdIF1 truncated and point mutants, and the
luciferase activity was assayed. Error bars represent S.E.M.
doi:10.1371/journal.pone.0066710.g004
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example in RusA and Rev [23,24]. The amino acid sequence of
residues 48-52, RRGRR, is arginine-rich and similar to an AT-
hook – an AT-hook being a small consensus sequence centred
around a glycine-arginine-proline (GRP) tripeptide [25]. The 1–75
aa region of TdIF1 might therefore bind to an AT-tract or other
specific DNA sequence. That the DNA-binding ability of the
TdIF1 N-terminus is weaker than that of a typical AT-hook may
be due to its sequence RRGRR, with a proline to arginine change
compared to the classic AT-hook GRP sequence.
We found that TdIF1 up-regulates RAB20 gene transcription
(Figure 5). RAB20 (Ras-related in brain 20) is a member of the
Rab family of small GTP-binding proteins and localizes to the
mitochondria or the vicinity of the Golgi apparatus [26,27].
RAB20 gene transcription is up-regulated by Hypoxia-inducible
transcription factor (HIF) under hypoxia [27]. The RAB20
promoter has a hypoxia responsive element (HRE) 7-bp upstream
from the transcriptional start site (TSS) in human cells. The
TdIF1-binding site is 1378-bp upstream from the TSS (Figure 5B),
suggesting that TdIF1 binds to the TdIF1-binding DNA sequence
to enhance transcription of the RAB20 gene promoter. It will be
interesting to investigate whether TdIF1 is involved in RAB20’s
gene expression under hypoxia. Furthermore, RAB20 gene
expression is reported to be up-regulated during the acute phase
of brain inflammation [28], in pancreatic tumour cell lines, and in
primary pancreatic carcinomas [26]. TdIF1 may control gene
expression of RAB20 in brain inflammation and pancreatic
tumour cells.
We identified the TdIF1-binding DNA sequence in several gene
promoters using the cisRED program. However, we cannot rule
out the possibility that the TdIF1-binding DNA sequence is
present upstream or downstream of the promoter regions that we
searched. When we searched for 59-GNTGCATG-39, instead of
59-GTTGCATG-39, in promoter regions using cisRED, we
obtained 102 genes (Table S3). Thus, there are many more
candidate TdIF1 target genes. Genome-wide mapping of the
TdIF1-binding sites by TdIF1 ChIP-seq analysis should help
elucidate the TdIF1-target genes, especially combined with
mRNA profiling in the presence or absence of TdIF1. mRNA
profiling experiments may also identify genes that are regulated by
TdIF1 indirectly. These experiments are presently underway in
our laboratory.
Since TdIF1 binds to a co-transcriptional factor TReP-132 [4],
we suspect that TdIF1 regulates gene transcription together with
TReP-132. TReP-132 is involved in the transcription of the
p450scc, p21, and p27 genes [9,29–33]. However, the TdIF1-
binding DNA sequence does not exist in these promoter regions,
implying that TdIF1 is not involved in transcriptional regulation of
these genes. It is possible that TdIF1 recruits TReP-132 to
Figure 5. TdIF1 regulates RAB20 gene transcription. (A) TdIF1
associates with the RAB20 promoter region. ChIP-qPCR was performed
using 293T cells expressing Flag-TdIF1, an anti-Flag antibody, and the
indicated sets of primers (Table S1). For negative controls, an anti-myc
antibody (aNega) and 293T cells not expressing Flag-TdIF1 (noOE) were
used. (B) Schematic structure of the RAB20 promoter region. The motif
of 59-GTTGCATG-39 (underlined) is positioned at -1597 bp from ATG of
RAB20 gene. An AT-tract (colored red) locates near the 59-GTTGCATG-39
motif. Primers used in ChIP-qPCR are shown below. HRE, hypoxia
responsive element; TSS, transcriptional start site. (C) TdIF1 regulates
RAB20 gene transcription. Total RNA was extracted from 293T cells
transfected with siRNAs against TdIF1 (siTdIF1) or negative control
siRNAs (siNega). The mRNA levels were calculated by the DDCt method
and normalized to each mRNA from siNega. DNTTIP1 encodes TdIF1.
Error bars represent S.E.M. Samples significantly different from the
control sample are indicated by asterisks (p,0.01).
doi:10.1371/journal.pone.0066710.g005
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promoter regions, and that the two proteins cooperate to control
transcription of genes such as RAB20.
TdIF1 is reported to interact with HDAC1 and HDAC2 during
M phase [10]. The HDACs usually repress transcriptional activity
by deacetylating histones [34]. HDAC1 and HDAC2 interact with
many transcriptional factors, including YY1, Rb binding protein-
1, Sp1, and ZEB1 [35–40], to regulate gene transcription. Since
TdIF1 functions as an enhancer of gene transcription, it is thought
that TdIF1’s binding to HDAC1 and HDAC2 in the M phase [10]
may inhibit their deacetylase activities. Alternatively, at some
specific promoters, TdIF1 may recruit HDAC1 and HDAC2 to
down-regulate gene transcription in M phase.
TdIF1 was originally identified as a protein that directly binds to
TdT [4], which is a member of the DNA polymerase X (polX)
family [41]. PolXs are involved in DNA repair, such as in base
excision repair and non-homologous end-joining [41]. Because
TdIF1 also binds to the other polX family members polb, polm,
and poll [5], it is possible that TdIF1 acts in DNA repair by
directly regulating polX family proteins. Other examples exist of
transcriptional factors that are also directly involved in DNA
repair, including FOXM1, KLF8, Sp1, and Tip60 [42–44]. Like
these transcriptional factors, TdIF1 appears to function in both
DNA repair and gene transcription.
Materials and Methods
Mutation, expression, and purification
Site-directed mutagenesis was performed by PCR using a Quick
Change site-directed mutagenesis kit (Agilent Technologies). Pairs
of mutagenic primers were used to construct the TdIF1 mutants,
mtN, mtHTH1, and mtHTH2 (Table S1). The primers for
TdIF1mtAT were described in Kubota et al. 2007 [5]. The
substituted bases are underlined in Table S1. The nucleotide
sequences were determined by the dideoxy termination method.
The cDNA fragments containing each mutation were sub-cloned
into the pPROEX-1 or pGEX-4T (GE Healthcare) vectors. The
procedures for protein expression and purification were described
previously [5].
GST pull-out assay
The GST pull-out assay was performed as described previously
[5]. Briefly, pcDNA3.1(+) (Life Technologies) plasmid digested
with Hae III was mixed with GST-TdIF1 or GST-TdIF1 mutants
bound to glutathione Sepharose 4B beads (GE Healthcare). After
washing the beads, the DNA fragments bound to TdIF1 or its
mutants were sequentially eluted with buffer A (50 mM Tris-HCl,
pH 7.4, 5 mM b-mercaptoethanol, 0.25% Tween 20, 10%
glycerol) containing 150–300 mM NaCl. The eluates were
analysed on a 5% non-denaturing polyacrylamide gel, followed
by silver staining.
Generation of double-stranded oligonucleotide library
A library of single-stranded oligonucleotides 59-TGCGGA-
TCCTGGTTGAGACG(N)36GTGCGTCAGGTGTCGACTGA-
39 was generated for the systematic evolution of ligands by
exponential enrichment (SELEX) experiments. The invariable 59-
and 39-flanking sequences contained BamHI and Sal I restriction
sites. Six hundred picomoles of oligonucleotides were incubated in
100 ml of polymerase reaction buffer containing 1200 pmol of
reverse primer (59-TCAGTCGACACCTGACGCAC-39), 0.2 mM
dNTPs, and 5 units of Ex Taq polymerase (TaKaRa) and treated as
follows: 5 min at 95uC, 20 min at 58 uC, and 20 min at 72uC. The
double-stranded oligonucleotides were separated on a 12%
polyacrylamide gel and purified from the gel.
SELEX experiment
In the first TdIF1-binding reaction, 180 ng of the double-
stranded oligonucleotides in the library were incubated with 100
ng of TdIF1 in a 10-ml reaction mixture containing 50 mM Tris-
HCl, pH 7.4, 80 mM NaCl, 10% glycerol, and 0.25% Tween 20,
for 60 min on ice. The reaction mixture was loaded onto a pre-
electrophoresed 6% polyacrylamide gel, and subjected to electro-
phoresis at 4uC and 100 V in 0.56TBE buffer (45 mM Tris-HCl,
pH 8.3, 45 mM boric acid, 0.5 mM EDTA). The DNA was
stained with ethidium bromide (EtBr). The TdIF1-bound DNA
was isolated from a gel slice (,86561 mm), crushed in 200 ml of
TE (10 mM Tris-HCl, pH 8.0, 1 mM EDTA)-0.1% SDS,
incubated at 90uC for 5 min, and rotated at 37uC overnight.
The DNA was extracted with phenol, precipitated with Ethachin-
mate (Wako), and resuspended in 30 ml of dH2O. PCR using
forward (59-TGCGGATCCTGGTTGAGACG-39) and reverse
primers was performed with 10 ml of the isolated DNA in 50 ml
10 mM Tris-HCl, pH 8.3, 50 mM KCl, 1.5 mM MgCl2, 0.2 mM
each dNTP, 25 pmol of each primer, and 2.5 units Taq
polymerase. PCR was performed with 10 cycles at 94uC for
30 sec, 56uC for 30 sec, and 72uC for 30 sec. The samples were
loaded onto a 6% polyacrylamide gel and separated by
electrophoresis at room temperature at 100 V in 0.56 TBE
buffer. The DNA was extracted from the gel, phenol-extracted,
ethanol-precipitated, and resuspended in 5 ml TE. Two microliters
of the 5 ml of recovered DNA were used for the next round of
selection. In the 2nd-10th rounds, the TdIF1 and DNA were
incubated in reaction buffer containing higher concentrations of
NaCl: 120 mM in the 2nd-8th rounds and 200 mM in the 9th and
10th rounds. After 10 rounds, the PCR products were digested
with Bam HI and Sal I and sub-cloned into pBluescript SK (pBS;
Agilent Technologies), and their DNA sequences were deter-
mined.
EMSA
EMSA was performed as described previously [5]. Briefly, a
biotin-labelled 32-bp AT-rich dsDNA (5 pmol) was incubated with
purified His-TdIF1 (100 ng) in the absence or presence of
competitors (5, 15, or 45 pmol) in a 10-ml final volume of binding
buffer (10 mM Tris-HCl, pH 7.5, 100 mM NaCl, 1 mM EDTA,
1 mM DTT, 5% glycerol). After electrophoresis, the DNA was
electrophoretically transferred to a positively charged nylon
membrane, Hybond-N+ (GE Healthcare). Biotin-labelled DNA
was detected using Streptavidin-HRP (GE Healthcare) and ECL
reagent (GE Healthcare).
Luciferase assay
A DNA fragment containing four repeats of the TdIF1-binding
sequence was inserted at the Bgl II site of the pGL3 promoter
(Promega). Reporter plasmids and the control plasmid pRL-TK
were transfected into 293T cells. After 24 h, the cells were lysed
and the Photinum pyralis and Renilla reniformis luciferase activities
(PLuc and RLuc) were measured by an ARVO63 plate reader
(PerkinElmer). The relative luciferase activity was calculated as the
PLuc divided by Rluc, and normalized to the value obtained with
the pGL3 promoter and pEGFP. The assay was performed in
triplicate. Statistical significance was determined by Student’s t-
test.
Quantitative chromatin immunoprecipitation-PCR
The chromatin immunoprecipitation (ChIP) assay was per-
formed using the Low Cell# ChIP Kit (Diagenode). 293T cells
were transiently transfected with pME-Flag-TdIF1. After harvest-
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ing the cells, the proteins and DNA were cross-linked in 1%
formaldehyde in PBS for 15 min. The reaction was stopped with
125 mM glycine. The cells were washed in PBS and then
suspended in ChIP buffer. The chromatin was fragmented with
a Covaris S220 focused-ultrasonicator (duty, 20%; intensity, 5;
cycles/burst, 200; at 4uC for 20 min; Covaris). After centrifugation
at 12,3006g for 20 min, the fragmented chromatin was mixed
with anti-DYKDDDDK-antibody (Wako)-coupled protein G-
magnetic beads for 2 h. After washing the beads, the proteins
were digested with Proteinase K for 30 min at 55uC. The samples
were boiled and centrifuged at 123006g for 1 min, and the
purified DNA was obtained from the supernatant.
The DNA was amplified and detected using Power SYBR
Green PCR Master Mix (Life Technologies) and the Applied
Biosystems 7300 Real Time PCR system (step 1, 95uC for 10 min;
step 2, 60 cycles of 95uC for 15usec and 60uC for 1 min; step 3,
95uC for 15 sec, 60uC for 30 sec, and 95uC for 15 sec). The DNA
was quantified using a predetermined amount of DNA as a
standard, and normalized to the value of the input DNA for the
ChIP assay. The DNA sequences of the primers are presented in
Table S1. The set of primers for the b-actin promoter is described
in Takahashi et al. 2006 [45].
TdIF1 knock-down using small interfering RNA
Three TdIF1-specific small interfering RNAs (siRNAs) and
negative control siRNA were designed and purchased from Cosmo
Bio. 293T cells were transfected with a cocktail of siRNAs using
Lipofectamine RNAiMAX (Life Technologies). The TdIF1 knock-
down was confirmed by Western blotting and Real-Time PCR.
Quantitative Reverse transcriptase PCR
Total RNA was purified from the TdIF1-knock-down or
negative control cells using ISOGEN II (Nippon Gene). The
cDNA was obtained by reverse transcription, amplified, and
detected using a Power SYBR Green RNA-to-Ct 1-Step Kit (Life
Technologies) and the Applied Biosystems 7300 Real Time PCR
system (step 1, 48uC for 30 min; step 2, 95uC for 10 min; step 3,
60 cycles of 95uC for 15 sec and 60uC for 1 min; step 4, 95uC for
15 sec, 60uC for 30 sec, and 95uC for 15 sec). The DNA
sequences of the primers are presented in Table S1. The DNA
levels were calculated by the comparative Ct (DDCt) method using
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as an
internal standard, and normalized to the value of the negative
control. The primers for RAB20 are described in Oleaga et al.
2012 [46]. Statistical differences were determined by Student’s t-
test.
Computational analysis
DISOPRED (http://bioinf.cs.ucl.ac.uk/disopred/), WebLogo
(http://weblogo.berkeley.edu/), and cisRED (http://www.cisred.
org/) were used.
Supporting Information
Table S1 Oligonucleotides used in this study.
(DOCX)
Table S2 Candidates of TdIF1-regulating genes having
59-GTTGCATG-39 in their promoter region predicted by
cisRED.
(XLS)
Table S3 Candidates of TdIF1-regulating genes having
59-GNTGCATG-39 in their promoter region predicted by
cisRED.
(XLS)
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